MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jocn.2019.12.059

Медицинская библиотека · Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2020

The potential neuromodulatory impact of subthalamic nucleus deep brain stimulation on Parkinson's disease progression.

Szlufik Stanislaw, Duszynska-Lysak Karolina, Przybyszewski Andrzej, Laskowska-Levy Ilona, Drzewinska Agnieszka, Dutkiewicz Justyna, Mandat Tomasz, Habela Piotr, Koziorowski Dariusz

Клиническое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

STN-DBS has been claimed to change progressionsymptomsin animal models of PD, but information is lacking about the possible neuromodulatory role of STN-DBS in humans. The aim of this prospective controlled study was to evaluate the long-term impact of STN-DBS on motor disabilities and cognitive impairment in PD patients in comparison to Best-Medical-Therapy (BMT) and Long-term-Post-Operative (POP) groups.

MATERIAL AND

METHODS

Patients were divided into 3 groups: the BMT-group consisted of 20 patients treated only with pharmacotherapy, the DBS-group consisted of 20 PD patients who underwent bilateral STN-DBS (examined pre- and postoperatively) and the POP-group consisted of 14 long-term postoperative patients in median 30 month-time after DBS. UPDRS III scale was measured during 3 visits in 9 ± 2 months periods (V1, V2, V3) in total-OFF phase. Cognitive assessment was performed during each visit in total-ON phase.

RESULTS

The comparable UPDRS III OFF gain was observed in both BMT-group and POP-group evaluations (p < 0.05). UPDRS III OFF results in DBS-group revealed significant UPDRS III OFF increase in ΔV2-V1 assessment (p < 0.05) with no significant UPDRS III OFF alteration in ΔV3-V2 DBS-group evaluation (p > 0.05). Cognitive assessment revealed significant alterations between DBS-group and BMT-group in working memory, executive functions and learning abilities (p < 0.05).

CONCLUSIONS

The impact of STN-DBS on UPDRS III OFF score and cognitive alterations suggest its neuromodulatory role, mainly during the first 9-18 months after surgery.

Для цитирования: Szlufik Stanislaw, Duszynska-Lysak Karolina, Przybyszewski Andrzej, Laskowska-Levy Ilona, Drzewinska Agnieszka, Dutkiewicz Justyna, Mandat Tomasz, Habela Piotr, Koziorowski Dariusz. The potential neuromodulatory impact of subthalamic nucleus deep brain stimulation on Parkinson's disease progression.. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2020. DOI: 10.1016/j.jocn.2019.12.059.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.